The impact of socio-economic circumstances on overall and grade-specific prostate cancer incidence: A population-based study

British Journal of Cancer

Volumn 107, Issue 3, 2012, Pages 575-582

  Shafique, K ^a   Oliphant, R ^a   Morrison, D S ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

high grade; incidence; low grade; prostate cancer; Scotland; socio economic inequalities

Indexed keywords

AGE; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER REGISTRY; CARSTAIRS SCORE; DESCRIPTIVE RESEARCH; DISEASE SEVERITY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; SCORING SYSTEM; SOCIAL STATUS; UNITED KINGDOM;

AGED; HUMANS; INCIDENCE; MALE; NEOPLASM GRADING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SCOTLAND; SOCIOECONOMIC FACTORS;

EID: 84864342528     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.289     Document Type: Article

References (32)

1. American Institute for Cancer Research, World Cancer Research Fund (2007) Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. American Institute for Cancer Research: Washington
2. Ben-Shlomo Y, Evans S, Ibrahim F, Patel B, Anson K, Chinegwundoh F, Corbishley C, Dorling D, Thomas B, Gillatt D, Kirby R, Muir G, Nargund V, Popert R, Metcalfe C, Persad R (2008) The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS cohort study. Eur Urol 53: 99-105
3. Bray F, Lortet-Tieulent J, Ferlay J, Forman D, Auvinen A (2010) Prostate cancer incidence and mortality trends in 37 European countries: An overview. Eur J Cancer 46: 3040-3052
4. Brewster D, Crichton J, Muir C (1994) How accurate are Scottish cancer registration data? Br J Cancer 70: 954-959
5. Brewster D, Muir C, Crichton J (1995) Registration of colorectal cancer in Scotland: an assessment of data accuracy based on review of medical records. Public Health 109: 285-292
6. Brewster DH, Fraser LA, Harris V, Black RJ (2000) Rising incidence of prostate cancer in Scotland: increased risk or increased detection? BJU Int 85: 463-472
7. Brewster DH, Stockton DL (2008) Ascertainment of breast cancer by the Scottish Cancer Registry: an assessment based on comparison with five independent breast cancer trials databases. Breast 17: 104-106
8. Carstairs V, Morris R (1990) Deprivation and health in Scotland. Health Bull (Edinb) 48: 162-175
9. Clegg LX, Reichman ME, Miller BA, Hankey BF, Singh GK, Lin YD, Goodman MT, Lynch CF, Schwartz SM, Chen VW, Bernstein L, Gomez SL, Graff JJ, Lin CC, Johnson NJ, Edwards BK (2009) Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control 20: 417-435
10. Collin SM, Martin RM, Metcalfe C, Gunnell D, Albertsen PC, Neal D, Hamdy F, Stephens P, Lane JA, Moore R, Donovan J (2008) Prostatecancer mortality in the USA and UK in 1975-2004: an ecological study. Lancet Oncol 9: 445-452
11. Davey Smith G, Hart C, Watt G, Hole D, Hawthorne V (1998) Individual social class, area-based deprivation, cardiovascular disease risk factors, and mortality: the Renfrew and Paisley Study. J Epidemiol Comm Health 52: 399-405
12. Donnelly DW, Gavin A (2011) Socio-economic inequalities in cancer incidence-the choice of deprivation measure matters. Cancer Epidemiol 35: e55-e61
13. Dutta RS, Philip J, Javle P (2005) Trends in prostate cancer incidence and survival in various socioeconomic classes: a population-based study. Int J Urol 12: 644-653
14. Evans HS, Moller H (2003) Recent trends in prostate cancer incidence and mortality in southeast England. Eur Urol 43: 337-341
15. Frankel S, Smith GD, Donovan J, Neal D (2003) Screening for prostate cancer. Lancet 361: 1122-1128
16. Grundmark B, Garmo H, Loda M, Busch C, Holmberg L, Zethelius B (2010) The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes. Cancer Epidemiol Biomark Prev 19: 2088-2096
17. Haas GP, Delongchamps N, Brawley OW, Wang CY, de la Roza G (2008) The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Can J Urol 15: 3866-3871
18. Information Services Division, NHS, National Services Scotland (2011) Cancer in Scotland. Information Services Division, NHS National Services Scotland: Edinburgh Johns LE, Houlston RS (2003) A systematic review and meta-analysis of familial prostate cancer risk. BJU Int 91: 789-794
19. Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19: 335-351
20. Liu L, Cozen W, Bernstein L, Ross RK, Deapen D (2001) Changing relationship between socioeconomic status and prostate cancer incidence. J Natl Cancer Inst 93: 705-709
21. Lund Nilsen TI, Johnsen R, Vatten LJ (2000) Socio-economic and lifestyle factors associated with the risk of prostate cancer. Br J Cancer 82: 1358-1363
22. Moore AL, Dimitropoulou P, Lane A, Powell PH, Greenberg DC, Brown CH, Donovan JL, Hamdy FC, Martin RM, Neal DE (2009) Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer. BJU Int 104: 1592-1598
23. National Cancer Intelligence Network (2011) Cancer incidence by deprivation England, 1995-2004 http://www.ncin.org.uk/publications/reports/ default.aspx (accessed on 10 November 2011).
24. Office of the Chief Statistician (2004) Analysis of Ethnicity in the 2001 Census. Summary report.Scottish Executive: Edinburgh
25. Pukkala E, Weiderpass E (2002) Socio-economic differences in incidence rates of cancers of the male genital organs in Finland, 1971-1995. Int J Cancer 102(6): 643-648
26. Rowan S (2007) Trends in cancer incidence by deprivation, England and Wales, 1990-2002. Health Stat Quart Off Natl Stat 36: 24-35
27. Sakr WA, Grignon DJ, Haas GP, Heilbrun LK, Pontes JE, Crissman JD (1996) Age and racial distribution of prostatic intraepithelial Neoplasia. Eur Urol 30: 138-144
28. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Paez A, Maattanen L, Bangma CH, Aus G, Carlsson S, Villers A, Rebillard X, van der Kwast T, Kujala PM, Blijenberg BG, Stenman UH, Huber A, Taari K, Hakama M, Moss SM, de Koning HJ, Auvinen A (2012) Prostate-cancer mortality at 11 years of follow-up. N Engl J Med 366: 981-990
29. Shack LG, Rachet B, Brewster DH, Coleman MP (2007) Socioeconomic inequalities in cancer survival in Scotland 1986-2000. Br J Cancer 97: 999-1004
30. Waterhouse JAH, Muir CS, Correa P, Powell J (1976) A New Measure of Age Standardized Incidence. The Cumulative Rate. In Cancer Incidence in Five Continents Vol. IIIIARC Scientific Publications No.15. International Agency for Research on Cancer: Lyon
31. Westlake S, Cooper N (2008) Cancer incidence and mortality: trends in the United Kingdom and constituent countries, 1993-2004. Health Stat Quarter Off Natl Stat 38: 33-46
32. Yin D, Morris C, Allen M, Cress R, Bates J, Liu L (2010) Does socioeconomic disparity in cancer incidence vary across racial/ethnic groups? Cancer Causes Control 21: 1721-1730